Lantheus Holdings Inc (LNTH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LNTH.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
LNTH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LNTH as an investment opportunity.
- Lantheus Holdings Inc's upside potential (average analyst target price relative to current price) is higher than 68.88% of all US stocks.
- The variance in analysts' estimates of LNTH is lower than 35.23% of all US stocks.
- LNTH has a higher number of analysts covering the stock than 35.45% of Pharmaceutical Products stocks.
- Lantheus Holdings Inc's average analyst price target is higher than 39.5% of all US stocks.
- The percent of analysts bearish on the stock of LNTH is less than nearly 100% of all US stocks.
- LNTH has a greater percentage of analysts bullish on the stock than nearly none of all US stocks.
- Lantheus Holdings Inc's change in bullishness amongst analysts is less than nearly 100% of all US stocks.
In the Pharmaceutical Products industry, SVRA, PSTI and ANIP are the three stocks most similar to Lantheus Holdings Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for LNTH? Use POWR Ratings for clearer insight into price direction.